Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to Tikkurila’s Capital Markets Day 2018 in Vantaa, Finland

Tikkurila OyjPress ReleaseAugust 17, 2018 at 11:00 a.m. (CET+1)Tikkurila invites investors, analysts and media representatives to its Capital Markets Day on Thursday November 29, 2018. The event will take place at Tikkurila headquarters in Vantaa (Kuninkaalantie 1, Vantaa). During the event, CEO Elisa Markula, SVP Offering Meri Vainikka (responsible for R&D, product portfolio and marketing) and CFO Jukka Havia will tell about industry developments and market outlook, Tikkurila’s strategy and growth initiatives as well as financial development. Program for Tikkurila’s Capital

Invitation to Valmet's Capital Markets Day on September 18, 2018

Valmet Oyj's press release on August 17, 2018 at 11:00 a.m. EET Valmet invites analysts and institutional investors to its Capital Markets Day on Tuesday, September 18, 2018. The event will take place in Helsinki, Finland, in Clarion Hotel (Tyynenmerenkatu 2). The aim of the Capital Markets Day is to provide information and an update on Valmet's strategy and business outlook. The day will include presentations by Pasi Laine, President and CEO; Kari Saarinen, CFO; and the Business Line Presidents. The event also provides opportunities to discuss with management. The presentations

King Abdullah University of Science and Technology (KAUST) Chooses Heliospectra for New Speed Breeding Program

GOTHENBURG, Sweden / SAN FRANCISCO, CA, 17 August 2018   Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a new order from King Abdullah University of Science and Technology (KAUST), a private international graduate-level institution located on the Red Sea. The prestigious University is starting a new speed breeding research program and has chosen Heliospectra’s fully adjustable ELIXIA LED lighting solution and HelioCORE™ light control software to light up their

Q-FREE – MINUTES EXTRAORDINARY GENERAL MEETING 17 AUGUST 2018

An Extraordinary General Meeting in Q-Free ASA was held on 17 August 2018 at the Company's office in Parkveien 55, Oslo, Norway. All proposals on the agenda were adopted cf. the notice that was published on the Oslo Stock Exchange on 13 July 2018, including approval of the proposed drop-down demerger, cf. also the notice that was published on the Oslo Stock Exchange on 30 June 2018. The complete minutes of the Extraordinary General Meeting is attached to this release and is available on www.q-free.com. This information is subject to the disclosure requirements pursuant to section 5 -

Notice Release of Report for Q2 2018

Please note that the report for the second quarter ended June 30, 2018 will be released on the 29th of August, 2018 at 9:00 am CET.An international conference call for investors and analysts will be held on September 4, 2018 at 3:00 pm CET. The dial-in number is: Standard International Access +44 (0) 20 3003 2666, Stockholm+46 (0) 8 50520424, Berlin +49 (0) 30 3001 90612, Copenhagen +45 3272 9273, New York +1 646 843 4608, Norway Local Oslo +47 2 156 3318, Paris +33 (0) 1 7037 7166, Rome +39 06 83360400, Washington DC Local number +1 202 204 1514. The meeting code is Corral Q2. For

Notification according to Chapter 9, Section 10 of the Securities Markets Act of change in holdings in YIT Corporation shares

YIT Corporation Stock Exchange Release August 17, 2018 at 10:30 a.m.YIT Corporation has on August 17, 2018 received an announcement under Chapter 9, Section 5 of the Securities Markets Act, according to which the holding of Virala Oy Ab has exceeded the threshold of 10 per cent. According to the announcement, the holding had exceeded the threshold on August 17, 2018. According to the announcement, the total number of YIT shares owned directly or through financial instruments by Virala Oy Ab is 10.14 per cent. YIT has one share series, each share entitling to one vote. The total number

RhoVac participates in two international conferences and several investment events in Sweden

RhoVac AB ("RhoVac") announces today that it will attend Nordic Life Science Days, Stockholm in September and at BIO-Europe, Copenhagen in November. The company will also attend three investment events in the fall.RhoVac will attend Nordic Life Science Days, Stockholm Waterfront, Stockholm between 10 and 12 September, and at BIO - Europe in Copenhagen, Denmark between 5 and 7 November. At BIO-Europe, over 2 200 different companies, academic institutions and other related organizations from more than 60 other countries attend. RhoVac's CEO Anders Ljungqvist will present the company at the

Ahlstrom-Munksjö Oyj: Managers' Transactions (Hannele Jakosuo-Jansson)

AHLSTROM-MUNKSJÖ OYJ, MANAGERS’ TRANSACTION RELEASE August 17, 2018 at 10:08 EEST____________________________________________ Person subject to the notification requirementName: Hannele Jakosuo-JanssonPosition: Member of the Board/Deputy member Issuer: Ahlstrom-Munksjö OyjLEI: 213800F2MJ5Z2TAQ1726 Notification type: INITIAL NOTIFICATIONReference number: 213800F2MJ5Z2TAQ1726_20180817083052_4____________________________________________ Transaction date: 2018-08-13Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000048418Nature of the transaction:

ExpreS2ion appoints CBO and IR partner

ExpreS2ion Biotechnologies ApS (“ExpreS2ion") has appointed Bent U. Frandsen, currently VP of Business Development, as Chief Business Officer (CBO). He will manage a proactive effort to substantially increase the customer base in the Company’s vaccine development and production services segment. Furthermore, ExpreS2ion appoints Honeybadger as non-exclusive IR partner on the Swedish market.The appointment of Bent U. Frandsen as CBO follows the strengthening of the Company’s offer to provide complete services in vaccine development and GMP production to early clinical trials based on its

Change in number of shares in Parans Solar Lighting AB (publ)

Conversion of convertible notes into shares under the financing agreement announced on November 21st 2017 and the Amendment Agreement announced on March 9th 2018.The date of conversion was August 16th 2018 and the number of Notes converted was 60. The number of Notes remaining under the fourth conversion in the second tranche for future conversion is 0. The number of shares and the number of votes before the conversion was 22 805 977. Through the conversion the number of shares and the number of votes has increased by 222 222. The total number of shares and the total number of votes

Nordic Mining ASA (OAX:NOM) - Interim report per 30 June 2018

Enclosed please find Nordic Mining’s interim report for the second quarter 2018 and a separate presentation. The interim report and company updates will be presented today, Friday 17 August 2018 at 10.00 (CET) in the company’s office (address details below). The presentation and Q&A session will be held in English and transferred via webcast (details for the webcast below). Important events in the second quarter 2018 and year-to-date 2018:Important events in the second quarter 2018 and year-to-date 2018: Engebø rutile and garnet project · Agreements with the main landowners at

Today, trading in Risk Intelligence A/S shares starts at Spotlight Stock Market

Risk Intelligence A/S ("Risk Intelligence") new share issue expired on 31 July, 2018, and provided the company with 12 MDKK before issue costs. Today, 17 August, 2018, trading in Risk Intelligences's shares starts at Spotlight Stock Market. The share is traded under the ticker RISK and ISIN code DK0061031978.Oversubscribed new share issue prior to listing The listing on Spotlight Stock Market has been preceded by a new share issue that provided Risk Intelligence approximately 12 MDKK before issue costs. In total, the issue was subscribed to approximately 45.6 MDKK including subscription

Interim report (January - June 2018)

Report period April – June, 2018 · Net sales in the period amounted to SEK 651 million (475), a growth of 37.1%. In constant currencies and adjusted for acquisitions, the organic growth amounted to 11.8%. · EBITDA amounted to SEK 142 million (90), corresponding to an EBITDA margin of 21.9% (19.0).  · EBITA amounted to SEK 108 million (60), corresponding to an EBITA margin of 16.6% (12.6). · Net financial income/expense includes net foreign exchange differences of SEK -48 million (-8). The majority part of the exchange rate loss for the period is attributable to the

Panion in FDA pre-submission conference

Panion Animal Health AB develops a unique new gene therapy treatment for dogs with drug-resistant epilepsy and the primary targeted market is the USA. The company has just been assigned to a pre-submission conference for this product with staff and experts from the FDA’s Center for Veterinary Medicine to take place in October in FDA-CVM’s office, Maryland, USA. At the meeting, the product will be introduced, the development plan will be discussed, and comments from the experts will be sought for a faster and smoother access to approval and marketing. The FDA has already received a

Evolution live with first USA Live Casino studio, Atlantic City, New Jersey

Evolution Gaming, leading provider of Live Casino solutions, today announced an historic breakthrough in the US casino gaming market — the opening of the company’s first USA Live Casino studio, in New Jersey.The new purpose-built Live Casino production studio for the US market is Evolution’s tenth Live Casino studio worldwide. The news follows recent announcements by Evolution that 888casino, Resorts Casino Hotel, Hard Rock Hotel & Casino Atlantic City, PlaySugarHouse.com operated by Rush Street Interactive and Ocean Resort Casino Atlantic City will all use the new Evolution US studio to

TargetEveryone appoints Torkel Johannessen as new Chief Executive Officer

The board of directors has reached an agreement with Torkel Johannessen to become the new CEO of TargetEveryone. Johannessen has been a board member of TargetEveryone since 2016 and will enter his new position starting October 1st this year. Johannessen comes from the role as Head of Sales and Omnichannel at VITA, the largest Cosmetics retailer in Norway. Johannessen has more than 15 years of experience within the digital space from the US, the UK and the Nordic region. He has previously worked for companies such as Match.com, Yahoo! and Egmont. Johannessen´s position as a board member will

XMReality AB (publ), Interim Report, April—June 2018

XMReality is growing and the strategy is resulting in new orders from new and existing customers in a steadily growing industrial market for Remote Guidance and Augmented Reality.XMReality is making its interim report April—June 2018 public, it is available in its entirety as an attached document and on the company's website, www.xmreality.com. The quarter, April–June 2018 · Net sales amounted to SEK 2,186 thousand (1,400) · Costs totalled SEK -11,620 thousand (-8,808) · The net loss was SEK -7,840 thousand (-5,215) · Net cash used amounted to SEK -8,333 thousand (47,498)

Green Landscaping secures extended contract in central Stockholm

Green Landscaping has been entrusted to continue carrying out outdoor maintenance services in the central city parks Kungsträdgården, Berzelii Park, Norra Bantorget and Strömparterren in Stockholm.Through a contract with the City of Stockholm Traffic and Public Transport Authority, Green Landscaping has been responsible for outdoor maintenance services in the parks since 2013. The services include ground maintenance, gardening, cleaning, snow removal and gritting. In accordance with the existing contract's extension option, the City of Stockholm Traffic and Public Transport Authority has

Crown Energy AB: Interim report, January-June 2018

Q2 – APRIL-JUNE 2018 · Revenue amounted to SEK 19,206 thousand (31,305). · Operating profit amounted to SEK 5,329 thousand (17,131), corresponding to SEK 0.01 per share (0.05). · Unrealised changes in Property values amounted to SEK -21,912 (20) thousand. · Profit before tax was SEK 187,749 thousand (-157,448), corresponding to SEK 0.39 per share (-0.44) and profit after tax was SEK 171,241 thousand (-153,767), corresponding to SEK 0.36 per share (-0.43). H1 – JANUARY-JUNE 2018 · Revenue amounted to SEK 39,835 thousand (59,089). · Operating profit amounted to SEK 12,

INVISIO Interim Report January–June 2018: Growth and continued strategic initiatives

CEO comment ”In comparison with the second quarter of 2017 this year’s quarter is characterized by increased sales and an improved gross margin. We have a strong position in NATO and our long-term customer contracts answer for the quarter’s sound sales and very good order intake. The determined initiatives now taking place in product development and in the market are aimed at ensuring future expansion and in the short perspective will imply some strain on earnings”, says Lars Højgård Hansen, CEO of INVISIO.April–June 2018 · Revenue: SEK 93.8 m (84.2) · Gross profit: SEK 55.3 m (

C-RAD AB – Interim report January-June 2018

C-RAD AB – Interim report January-June 2018 PROFITABLE QUARTER, REVENUE INCREASED BY 61 PERCENT SECOND QUARTER 2018  · Order intake: 56.4 (49.3) MSEK, 14%. · Revenues: 51.9 (32.2) MSEK, 61%. · Operating profit: 2.0 (-4.1) MSEK. · Net results after tax: 1.6 (-4.3) MSEK · Result per share: 0.05 (-0.14) SEK. · Warrant program 2018/2021 fully subscribed Comments from Tim Thurn, CEO: SIGNIFICANT GROWTH IN REVENUE We are closing the second quarter with significant growth in revenue, an operating profit and a considerable increase in order intake. The result is

Idogen extends the project portfolio to projects in autoimmune diseases

Idogen AB (”Idogen”) announces today that the company has decided to expand its project portfolio with a third therapeutic area; autoimmune diseases. Idogen´s research department is currently evaluating the potential of the company's technology in a group of autoimmune diseases where there is a major medical need, and where a treatment has the potential to be granted orphan drug status.Idogen´s technology is designed for the development of tolerogenic cell therapy in a variety of areas, especially treatment of anti-drug antibodies, autoimmune diseases and organ rejection after

NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF IMPACT COATINGS AB (PUBL)

Shareholders in Impact Coatings AB (publ), org.nr 556544-5318, are hereby invited to attend the Extraordinary General Meeting of Shareholders (“EGM”) on Tuesday, 11 September 2018 at 09:00 a.m. at the company’s Certified Adviser, Redeye AB, located at Mäster Samuelsgatan 42 in Stockholm.Right to attend Shareholders who wish to attend the EGM shall both be registered in the shareholder registry maintained by Euroclear Sweden AB by Wednesday, 5 September 2018, and notify attendance to the company latest Wednesday, 5 September 2018 via e-mail to anmalan@impactcoatings.se or post to Impact

There are no items matching the current filter
There are no more items matching the current filter
Back to top